GeneBio Systems
Recombinant CD39 Monoclonal Antibody
Recombinant CD39 Monoclonal Antibody
SKU:AN301981L
Couldn't load pickup availability
Size::50μL
Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping:Ice bag
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Monoclonal Antibodies;Recombinant Antibodies
Abbreviation:CD39
Target Synonym:SPG;Ecto-ATP diphosphohydrolase;Ectonucleoside triphosphate diphosphohydrolase;ENTPD;ENTPD1;ATPDase;CD39;NTPDase-1;SPG64;CD 39;NTPDase1;Ecto-apyrase;Ectonucleoside triphosphate diphosphohydrolase 1;NTPDase 1;Ecto-ATP diphosphohydrolase 1;Lymphoid cell activation antigen;NTPDase-1;CD39 antigen;DKFZp686D194;DKFZp686I093;Ecto apyrase;Ecto ATP diphosphohydrolase;Ecto-ATPase 1;Ecto-ATPDase 1;ENTP1;ENTPD 1;FLJ40921;FLJ40959
Research Areas:Immunology
Conjugation:Unconjugated
Host:Rabbit
Species reactivity:Human;Mouse
Application:WB
Isotype:IgG,κ
Clonality:Monoclonal;Recombinant
Clone NO.:A701
UNIProt ID:P49961
Accession:
Background:CD39,also known as ectonucleoside triphosphate diphosphohydrolase 1 (NTPDase 1), is a multi-pass membrane ectoenzyme that metabolizes adenosine-5'-triphosphate (ATP) to regulate purinergic signaling. Purinergic signaling by extracellular ATP and its metabolites regulate many biological processes, including vascular tone, digestion, neuronal function, and inflammation in both normal and diseased states. CD39 is expressed in endothelial cells in the vasculature to regulate local platelet purinergic signaling via metabolism of ATP to adenosine. Accordingly, CD39 regulates platelet activation aggregation and contributes to the antithrombotic properties of endothelial cells. ATP and its metabolites also finely modulate the activity of T cells and macrophages. Immunomodulation is regulated, in part, by the availability of extracellular ATP and adenosine, suggesting that CD39 may play an immunosuppressive role in the tumor microenvironment.
Concentration:1 mg/mL
Immunogen:Recombinant fragment
Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification method:Protein A purified
Dilution:WB 1:1000-1:2000
Calculated MW:58 kDa
ObservedMW:78 kDa
